94 related articles for article (PubMed ID: 8829492)
1. Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation.
Tsutsui K; Shirasaki F; Takata M; Takehara K
Dermatology; 1996; 192(2):120-4. PubMed ID: 8829492
[TBL] [Abstract][Full Text] [Related]
2. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study.
Cai D; Chen XP; Wei DC; Zhang Q; Chen SQ; He WZ
J Int Med Res; 2019 Jul; 47(7):3014-3024. PubMed ID: 31142174
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic treatment in livedo vasculitis.
Yamamoto M; Danno K; Shio H; Imamura S
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):57-62. PubMed ID: 3346409
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of restenosis by beraprost sodium (a prostaglandin I2 analogue) in the atherosclerotic rabbit artery after angioplasty.
Isogaya M; Yamada N; Koike H; Ueno Y; Kumagai H; Ochi Y; Okazaki S; Nishio S
J Cardiovasc Pharmacol; 1995 Jun; 25(6):947-52. PubMed ID: 7564340
[TBL] [Abstract][Full Text] [Related]
6. The effect of PGI2 analogue on vascular endothelial function and platelet aggregation in patients with NIDDM.
Nishimura M; Nozaki O; Nakano H; Tsuchida H; Yamada K
J Diabetes Complications; 1995; 9(4):330-3. PubMed ID: 8573759
[TBL] [Abstract][Full Text] [Related]
7. A dose-effect study of beraprost sodium in intermittent claudication.
Lievre M; Azoulay S; Lion L; Morand S; Girre JP; Boissel JP
J Cardiovasc Pharmacol; 1996 Jun; 27(6):788-93. PubMed ID: 8761844
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.
Kainoh M; Maruyama I; Nishio S; Nakadate T
Biochem Pharmacol; 1991 Apr; 41(8):1135-40. PubMed ID: 1706920
[TBL] [Abstract][Full Text] [Related]
9. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
[TBL] [Abstract][Full Text] [Related]
10. Therapy of livedo vasculitis with pentoxifylline.
Ely H; Bard JW
Cutis; 1988 Nov; 42(5):448-53. PubMed ID: 3197446
[TBL] [Abstract][Full Text] [Related]
11. Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Ueno Y; Kawashima A; Koike H; Nishio S
Thromb Res; 1995 Jan; 77(2):193-8. PubMed ID: 7740511
[No Abstract] [Full Text] [Related]
12. Effects of beraprost and cilostazol and renal function on serum thrombomodulin levels in diabetic patients.
Hayakawa T; Shouzu A; Nishikawa M; Miyake Y; Shimizu H; Omoto S; Inada M
Arzneimittelforschung; 2000 Jun; 50(6):535-8. PubMed ID: 10918946
[TBL] [Abstract][Full Text] [Related]
13. [Systemic lupus erythematosus with pulmonary hypertension--normalization of pulmonary artery pressure by long-term administration of beraprost sodium].
Ubukata M; Motegi M; Sendo Y; Suzuki T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1307-12. PubMed ID: 8583727
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
Kim KM; Kim H; Chi HS; Park JS; Kim SB
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):262-5. PubMed ID: 20124989
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.
Ueno Y; Koike H; Annoh S; Nishio S
Prostaglandins; 1997 Apr; 53(4):279-89. PubMed ID: 9167214
[TBL] [Abstract][Full Text] [Related]
16. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
[TBL] [Abstract][Full Text] [Related]
17. Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.
Sakata K; Hoshino T; Yoshida H; Kaburagi T; Takada A
Cardiovasc Drugs Ther; 1995 Aug; 9(4):601-7. PubMed ID: 8547211
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1521-4. PubMed ID: 24144760
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy in atrophie blanche and livedo vasculitis.
Drucker CR; Duncan WC
J Am Acad Dermatol; 1982 Sep; 7(3):359-63. PubMed ID: 7130497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
